Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

NCT00806819

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Boehringer Ingelheim Investigational Site Downy, California, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Boehringer Ingelheim Investigational Site Fullerton, California, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
View all 163 locations
View Trial Details
Completed

Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer

NCT00349102

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Centre Oscar Lambret Lille, France
  • Centre Léon Bérard Lyon, France
  • Institut Curie Paris, France
  • Hôpital de la Pitié Salpêtrière Paris, France
View Trial Details
Completed

Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00842712

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Antwerpen (Edegem), Belgium
  • Research Site Brasschaat, Belgium
  • Research Site Brussels, Belgium
  • Research Site Gosselies, Belgium
View all 44 locations
View Trial Details
Completed

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

NCT00932451

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 280 locations
View Trial Details
Completed

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

NCT00932893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Arkansas for Medical Research, Winthrop Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
View all 264 locations
View Trial Details

Related conditions